loading

Brainstorm Cell Therapeutics Inc Stock (BCLI) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Research and Development
43.40%
0.961
1.698 3.33 2.794 2.924
Operating Income/Loss
48.50%
-2.474
-4.804 -6.035 -5.449 -5.151
Income/Loss From Continuing Operations Before Tax
39.03%
-3.401
-5.578 -1.226 -5.329 -5.059
Income/Loss From Continuing Operations After Tax
39.03%
-3.401
-5.578 -1.226 -5.329 -5.059
Net Income/Loss
39.03%
-3.401
-5.578 -1.226 -5.329 -5.059
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,195%
64.74
2.8204 44.25 39.70 36.74
Diluted Average Shares
2,195%
64.74
2.8204 44.25 39.70 36.74
Basic Earnings Per Share
54.55%
-0.05
-0.11 -0.03 -0.13 -0.14
Diluted Earnings Per Share
54.55%
-0.05
-0.11 -0.03 -0.13 -0.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$75.07
price up icon 1.39%
$305.39
price down icon 0.55%
$19.19
price down icon 3.62%
$32.68
price down icon 0.52%
$97.47
price down icon 2.84%
biotechnology ONC
$254.57
price up icon 1.89%
Cap:     |  Volume (24h):